Self-Administered Drug Exclusion List (SAD List)
October 1st, 2023
The CMS self-administered drug exclusion list contains drugs that are usually self-administered by the patient and, therefore, are not typically covered by Medicare when provided in an outpatient setting such as a hospital outpatient department. This is because Medicare Part B generally does not cover the cost of self-administered drugs that beneficiaries would typically take on their own.
BuyandBill.com republishes the self-administered drug exclusion list in conjunction with the CMS data file. The SAD list can be found here:
HCPCS Code | HCPCS Code Descriptor | Brand Name | Exclusion Effective Date |
---|---|---|---|
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Rebif® (Interferon Beta–1A, 1 mcg) | 7/16/17 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Tesamorelin (Egrifta ™) | 7/16/17 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Sogroya® (somapacitan-beco) | 11/15/21 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Pasireotide (Signifor®) | 11/15/21 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Risankizumab-rzaa (Skyrizi™) subcutaneous use* | 1/12/20 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | ofatumumab (Kesimpta®) subcutaneous use* | 7/24/22 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | tralokinumab-idrm (Adbry™) | 11/13/22 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | All insulin products | 12/11/22 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | tirzepatide (Mounjaro™) | 12/11/22 |
C9399 | UNCLASSIFIED DRUGS OR BIOLOGICALS | Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) | 6/25/23 |
J0129 | INJECTION, ABATACEPT, 10 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) | Orencia® subcutaneous use* | 4/1/21 |
J0135 | INJECTION, ADALIMUMAB, 20 MG | Humira | 2/1/08 |
J0270 | INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) | Caverject, Edex | 2/1/08 |
J0364 | INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG | Apokyn® | 4/1/21 |
J0490 | INJECTION, BELIMUMAB, 10 MG | Benlysta®, subcutaneous use* | 4/1/21 |
J0593 | INJECTION, LANADELUMAB-FLYO, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) | Takhzyro® | 12/2/19 |
J0599 | INJECTION, C-1 ESTERASE INHIBITOR (HUMAN), (HAEGARDA), 10 UNITS | Haegarda® | 1/1/19 |
J0630 | INJECTION, CALCITONIN SALMON, UP TO 400 UNITS | Calcimar, Miacalcin | 2/1/08 |
J0801 | INJECTION, CORTICOTROPIN (ACTHAR GEL), UP TO 40 UNITS | Acthar® Gel | 10/1/23 |
J0802 | INJECTION, CORTICOTROPIN (ANI), UP TO 40 UNITS | Purified Cortrophin Gel® | 10/1/23 |
J1324 | INJECTION, ENFUVIRTIDE, 1 MG | Fuzeon | 2/1/08 |
J1438 | INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) | Enbrel | 2/1/08 |
J1595 | INJECTION, GLATIRAMER ACETATE, 20 MG | Copaxone™ | 2/1/08 |
J1628 | INJECTION, GUSELKUMAB, 1 MG | Tremfya® (guselkumab) | 4/1/21 |
J1675 | INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS | Supprelin LA™ | 2/1/08 |
J1744 | INJECTION, ICATIBANT, 1 MG | Firazyr™ | 11/15/11 |
J1811 | INSULIN (FIASP) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS | Fiasp® for insulin pump use | 9/3/23 |
J1812 | INSULIN (FIASP), PER 5 UNITS | Fiasp® injection* | 9/3/23 |
J1813 | INSULIN (LYUMJEV) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS | Lyumjev® for insulin pump use | 9/3/23 |
J1814 | INSULIN (LYUMJEV), PER 5 UNITS | Lyumjev® injection* | 9/3/23 |
J1815 | INJECTION, INSULIN, PER 5 UNITS | Humalog, Humulin, Iletin, Insulin Lispro, Novo Nordisk, NPH, Pork Insulin, Regular Insulin, Ultralente, Velosulin, Humulin R, Iletin II Regular Port, Insulin Purified Pork, ReliOn, Lente Iletin I, Novolin R, Humulin R U-500 | 2/1/08 |
J1815 | INJECTION, INSULIN, PER 5 UNITS | All insulin products | 12/11/22 |
J1817 | INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS | All insulin products | 12/11/22 |
J1817 | INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS | Humalog, Humulin, Vesolin BR, Iletin II NPH Pork, Lantus, Lispro-PFC, Novolin, Novolog, Novolog Flexpen, Novolog Mix, ReliOn Novolin | 2/1/08 |
J1826 | INJECTION, INTERFERON BETA-1A, 30 MCG | Avonex Pen®, Rebif®, Rebif® Rebidose® | 11/15/21 |
J1830 | INJECTION, INTERFERON BETA-1B, 0.25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) | Betaseron™ | 2/1/08 |
J1941 | INJECTION, FUROSEMIDE (FUROSCIX), 20 MG | Furoscix® | 9/3/23 |
J2170 | INJECTION, MECASERMIN, 1 MG | Iplex ™ Increlex™ | 2/1/08 |
J2212 | INJECTION, METHYLNALTREXONE, 0.1 MG | Relistor ™ | 2/15/13 |
J2354 | INJECTION, OCTREOTIDE, NON-DEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG | Sandostatin™, subcutaneous use* | 2/1/08 |
J2440 | INJECTION, PAPAVERINE HCL, UP TO 60 MG | Papaverine HCL | 2/1/08 |
J2940 | INJECTION, SOMATREM, 1 MG | Protropin™ | 2/1/08 |
J2941 | INJECTION, SOMATROPIN, 1 MG | Genotropin™ | 2/1/08 |
J3030 | INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) | Imitrex™ | 2/1/08 |
J3031 | INJECTION, FREMANEZUMAB-VFRM, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) | Ajovy™ | 4/1/21 |
J3110 | INJECTION, TERIPARATIDE, 10 MCG | Forteo™ | 2/1/08 |
J3355 | INJECTION, UROFOLLITROPIN, 75 IU | Metrodin, Bravelle, Fertinex | 2/1/08 |
J3357 | USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG | Stelara® | 11/15/21 |
J3490 | UNCLASSIFIED DRUGS | Sogroya® (somapacitan-beco) | 11/15/21 |
J3490 | UNCLASSIFIED DRUGS | Abaloparatide (Tymlos™) | 7/16/18 |
J3490 | UNCLASSIFIED DRUGS | Albiglutide (Tanzeum™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Alirocumab (Praulent™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Dulaglutide (Trulicity™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | etanercept-szzs (Erelzi) | 11/15/16 |
J3490 | UNCLASSIFIED DRUGS | Evolocumab (Repatha™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Insulin Glargine (Toujeo SoloStar™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Insulin Glargine (Lantus SoloStar™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Sarilumab (Kevzara™) | 4/1/21 |
J3490 | UNCLASSIFIED DRUGS | Ixekizumab (Taltz™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Liraglutide (Victoza ™) | 10/16/11 |
J3490 | UNCLASSIFIED DRUGS | Liraglutide (Saxenda™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Methotrexate (Rasuvo™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Methotrexate (Otrexup™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Metreleptin (Myalept™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Mipomersen sodium (Kynamro™) | 9/15/13 |
J3490 | UNCLASSIFIED DRUGS | Parathyroid hormone (Natpara™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Pasireotide (Signifor™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Peginterferon beta-1a (Plegridy™) | 6/15/16 |
J3490 | UNCLASSIFIED DRUGS | Pramlintide (Symlin™) | 2/1/08 |
J3490 | UNCLASSIFIED DRUGS | Rebif® (Interferon Beta–1A, 1 mcg) | 7/16/17 |
J3490 | UNCLASSIFIED DRUGS | Tesamorelin (Egrifta™) | 10/16/11 |
J3490 | UNCLASSIFIED DRUGS | TriMix™ | 10/16/11 |
J3490 | UNCLASSIFIED DRUGS | Quadmix (+ Atropine) | 7/16/17 |
J3490 | UNCLASSIFIED DRUGS | Adalimumab-atto (AMJEVITA™) | 2/15/17 |
J3490 | UNCLASSIFIED DRUGS | Golimumab (SIMPONI) | 2/15/17 |
J3490 | UNCLASSIFIED DRUGS | Risankizumab-rzaa (Skyrizi™) subcutaneous use* | 1/12/20 |
J3490 | UNCLASSIFIED DRUGS | ofatumumab (Kesimpta®) subcutaneous use* | 7/24/22 |
J3490 | UNCLASSIFIED DRUGS | tralokinumab-idrm (Adbry™) | 11/13/22 |
J3490 | UNCLASSIFIED DRUGS | All insulin products | 12/11/22 |
J3490 | UNCLASSIFIED DRUGS | tirzepatide (Mounjaro™) | 12/11/22 |
J3490 | UNCLASSIFIED DRUGS | Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) | 6/25/23 |
J3590 | UNCLASSIFIED BIOLOGICS | Adalimumab-aacf (Idacio®), Adalimumab-afzb (Abrilada™), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry) | 6/25/23 |
J3590 | UNCLASSIFIED BIOLOGICS | All insulin products | 12/11/22 |
J3590 | UNCLASSIFIED BIOLOGICS | tirzepatide (Mounjaro™) | 12/11/22 |
J3590 | UNCLASSIFIED BIOLOGICS | tralokinumab-idrm (Adbry™) | 11/13/22 |
J3590 | UNCLASSIFIED BIOLOGICS | ofatumumab (Kesimpta®) subcutaneous use* | 7/24/22 |
J3590 | UNCLASSIFIED BIOLOGICS | adalimumab-adbm (Cyltezo™ ) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Anakinra (Kineret ™) | 2/1/08 |
J3590 | UNCLASSIFIED BIOLOGICS | Asfotase-alfa (Strensiq®) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Brodalumab (Siliq) | 7/16/17 |
J3590 | UNCLASSIFIED BIOLOGICS | Dupilumab (Dupixent) | 7/16/17 |
J3590 | UNCLASSIFIED BIOLOGICS | erenumab-aooe (Aimovig™) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Exenatide,(Byetta ™) | 10/16/08 |
J3590 | UNCLASSIFIED BIOLOGICS | Exenatide (Bydureon™) | 6/15/16 |
J3590 | UNCLASSIFIED BIOLOGICS | Galcenezumab-gnlm (Emgality™) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Peginterferon alfa-2b, (Pegintron™ Sylatron™) | 2/1/08 |
J3590 | UNCLASSIFIED BIOLOGICS | Pegvisomant, (Somavert™ ) | 2/1/08 |
J3590 | UNCLASSIFIED BIOLOGICS | Rebif® (Interferon Beta–1A, 1 mcg) | 7/16/17 |
J3590 | UNCLASSIFIED BIOLOGICS | Sarilumab (Kevzara®) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | secukinumab (Cosentyx ™) | 6/15/15 |
J3590 | UNCLASSIFIED BIOLOGICS | Semaglutide (Ozempic®) | 4/1/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Risankizumab-rzaa (Skyrizi™) subcutaneous use* | 1/12/20 |
J3590 | UNCLASSIFIED BIOLOGICS | Sogroya® (somapacitan-beco) | 11/15/21 |
J3590 | UNCLASSIFIED BIOLOGICS | Ropeginterferon alfa-2b-njft (BESREMI®) | 4/24/22 |
J9212 | INJECTION, INTERFERON ALFACON-1, RECOMBINANT, 1 MICROGRAM | Infergen | 2/1/08 |
J9213 | INJECTION, INTERFERON, ALFA-2A, RECOMBINANT, 3 MILLION UNITS | Peginterferon alfa-2a, (Pegasys ®, Pegasys ® Proclick™) | 2/15/13 |
J9216 | INJECTION, INTERFERON, GAMMA 1-B, 3 MILLION UNITS | Actimmune™ | 2/1/08 |
J9218 | LEUPROLIDE ACETATE, PER 1 MG | Lupron™ | 2/1/08 |
Q3027 | INJECTION, INTERFERON BETA-1A, 1 MCG FOR INTRAMUSCULAR USE | Avonex™ | 1/1/14 |
Q3028 | INJECTION, INTERFERON BETA-1A, 1 MCG FOR SUBCUTANEOUS USE | Rebif™ | 1/1/14 |
Q5131 | INJECTION, ADALIMUMAB-AACF (IDACIO), BIOSIMILAR, 20 MG | Idacio® | 9/3/23 |